Investorideas.com
Search  Follow Investorideas on Twitter  Investorideas is on Facebook  Investorideas is on Google Plus  Investorideas is on Youtube  Investorideas is on Pinterest  Investorideas is on tumblr  Investorideas is on LinkedIn  Investorideas RSS 


Investorideas podcasts on iTunes, Google Play Music and iHeart.com    Investorideas.com potcasts - cannabis news and stocks to watch plus insight from thought leaders and experts    Investorideas.com crypto corner    Play by Play – the latest sports headlines and sports stock news

 

Join Investor Ideas Members to access the Renewable Energy stocks directory, water stocks, biotech stocks, defense stocks directories and the Insiders Corner

Investor Ideas #Potcasts; #Cannabis News and Stocks on the Move; Part 2 with K. Lance Anderson of Dickinson Wright Discussing Cannabis IP in the U.S.

July 6th Potcast sponsored by Lexaria Bioscience Corp. (CSE: $LXX.C) (OTC: $LXRP) and its new disruptive drug delivery platform: DehydraTECH

Investorideas.com podcasts

 

Pt. Roberts, WA; Delta, BC - July 6, 2018 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its "potcast" site, www.potcasts.ca release today's edition of its series, Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to today's podcast, part 2:

http://www.investorideas.com/Audio/Podcasts/2018/070618-LanceAnderson.mp3

Investor Ideas #Potcasts; #Cannabis News and Stocks on the Move; Part 2 with K. Lance Anderson of Dickinson Wright Discussing Cannabis IP in the U.S.

Listen to previous podcast, part one:

http://www.investorideas.com/Audio/Podcasts/2018/070218-LanceAnderson.mp3

Investor Ideas #Potcasts; #Cannabis News and Stocks on the Move; K. Lance Anderson, intellectual property attorney, discusses cannabis sector

Today's podcast overview/transcript:

Good afternoon and welcome to another Investorideas.com potcast ; looking at cannabis news, stocks to watch as well as insights from thought leaders and experts. Today we will be finishing our two-part interview with K. Lance Anderson of Dickinson Wright where we will discuss the cannabis market and the laws surrounding it.

  1. Lance Anderson has extensive experience preparing and negotiating technology and intellectual property-focused transactions, as well as technology aspects of mergers and acquisitions, joint ventures, and other complex commercial transactions. A registered patent attorney, Mr. Anderson also conducts patent prosecution, due diligence for licensing, and acquisitions, technology agreements, strategic planning, patent prosecution, trade secrets, employment mobility, and related operational legal issues.

Prior to private practice, Lance served for over ten years as in-house counsel and lead intellectual property attorney for both a large public research university system and an early stage venture capital company, overseeing all facets of intellectual property development, management, and transactions. His experience and background contribute to skill sets applicable to technology transfer and emerging technology, high-tech, health-IT, agricultural biotechnology, pharmaceuticals/life sciences, consumer products, oil & gas, and renewable energy.

Lance represents clients within the innovation and research enterprise including R&D, clinical and regulatory matters, strategic collaborations, CRADA's, manufacturing, distribution, engineering services, institutional technology transfer, confidentiality and materials exchange, and related alliances. In addition to representing clients on intellectual property issues, he has been involved in many aspects of corporate law, operations, financing and litigation ranging from start-up and early stage companies to mature market leaders.

Dickinson Wright is positioned as one of the only full-service law firms to welcome clients operating in this industry and to provide specialized counsel both to clients operating with state-issued licenses and to businesses providing goods and services to the industry.

In Part 2 of our interview with K. Lance Anderson we continue discussing the state by state system in the US as well as the patent laws in the cannabis market.

In regard to the limitations or "glass ceiling" placed on the Cannabis market in the US with expansion internationally and nationally, Anderson stated that "to have that level of detail required for compliance, is always going to be a burden. I think it will continue to hold back US companies that are operating in that way."

When asked about the future of cannabis and what we might look forward to in the industry Anderson went on to talk about the innovations in delivery methods. "Think about the cannabis product as an edible. It is an oil, and it has to be metabolized by the liver, called a first pass metabolism requirement and in essence it's poorly available. It's not a very efficient process of orally administrating a cannabis product. What you're seeing are innovations to address that. Maybe it's more efficient uptake, which might mean higher bio-availability, or maybe its stability. Maybe it's the rapid onset of the desired effects. Those are coming out. Someday you're going to be able in 10 minutes to ingest something orally and have the induced effects. On the other hand, there are antagonists that out there. I think what we will see is the ability for a customer to consume something for lunch and enjoy themselves and then be able to turn that off. The ability to focus in on what I call designed delivery mechanisms to meet everyday products and everyday users."

We also discussed the current state and future of patent laws regarding plant strains and breeder's rights. "You see the opportunity for breeder's rights such as plant patents, to be taken advantage of, but that doesn't necessarily mean you won't have access to those innovative new lines. What it does mean is that there's some reasonable amount of protection from others asexually propagating that plant. It may position these breeders to benefit for a while. But at the end of the day can you protect the genetics of the cannabis plant from the context of certain traits? There are various groups that want to make sure certain genomes are sequenced and released and that will put a cushion between the innovators and the protections they will be able to take advantage of. You will see people take advantage of that, but I don't think it will get to the level of the soybean market being 90% controlled by Monsanto."

In continuing to discuss cannabis in comparison to agriculture and genetic modification and plant patents. "Consumers aren't going to accept genetically modified weed. It just won't happen. I think you will see it naturally balance with regard to innovation and the protection of those innovations in contrast to people having access to strains they want to have access to. With the extraction method and the advent of distillate as a source material for processing oils for vaporizers; the argument there is that it's cleaner and that it doesn't have the impurities that a butane or CO2 based solvent would have. Those are selling points. Those are well received by the industry."

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment

This podcast is sponsored by Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

Lexaria Bioscience Corp. has developed and out-licenses its disruptive delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and has patents granted in the USA and in Australia for utilization of its DehydraTECHTM delivery technology. Lexaria's technology provides increases in intestinal absorption rates; more rapid delivery to the bloodstream; and important taste-masking benefits, for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. www.lexariabioscience.com

Sign up to get the news alerts including the daily podcast and transcript for Investor ideas potcasts

Subscribe to the new cannabis podcast series:

http://www.investorideas.com/rss/feeds/Podcasts-Cannabis.xml

Or visit http://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

To hear more Investorideas.com podcasts visit: http://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes, Google Play Music, Stitcher and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Ideas

Investorideas.com is a meeting place for global investors, featuring news, stock directories, video, company profiles, interviews and more in leading sectors.

Investorideas.com cannabis/marijuana and hemp content now includes http://cannabisstocknews.blogspot.com on Blogger.com: the Investorideas.com news and stock directory pages, a cannabis investor group on Linkedin.com , the 420 Cannabis Investor ideas www.420cannabisinvestorideas.com, and the new AI site Global Cannabis Investing at www.Globalcannabisinvesting.com

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) is a media sponsor of the podcast starting July 5 2018 more info http://www.investorideas.com/About/News/Clientspecifics.asp

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Please read Investorideas.com privacy policy: http://www.investorideas.com/About/Private_Policy.asp

To sponsor this podcast or be a guest

Contact Investorideas.com

http://www.investorideas.com/About/Contact.asp

800-665-0411



Marijuana / Hemp Stocks

Marijuana / Hemp Stocks at Cannabisinvestorideas.com and Investorideas.com

Like Marijuana / Hemp Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing

Also check out our AI blog Global Cannabis Investing - features Investor Ideas Cannabis news